Inc. Cuts Stake in AbbVie Inc (NYSE:ABBV)

Marco Green
January 14, 2018

About 66,226 shares traded or 109.42% up from the average. It has underperformed by 6.07% the S&P500.

Verity & Verity Llc increased Abbvie Inc (ABBV) stake by 20.71% reported in 2017Q3 SEC filing. Evanson Asset Management Llc sold 27,095 shares as the company's stock rose 12.78% with the market. Capital Research Global Investors now owns 178,274,835 shares of the company's stock valued at $12,926,708,000 after acquiring an additional 2,130,919 shares during the last quarter. Rainier Investment Management Llc who had been investing in Elbit Sys Ltd for a number of months, seems to be bullish on the $5.34B market cap company. They expect $1.43 earnings per share, up 19.17 % or $0.23 from last year's $1.2 per share. About 8.22M shares traded or 15.02% up from the average.

AbbVie (NYSE:ABBV) last released its quarterly earnings data on Friday, October 27th. It has underperformed by 36.65% the S&P500.

Investors sentiment increased to 1.17 in Q3 2017. (NASDAQ:OVAS), its shares were trading at $1.11 a retreat of $0, on the trading floor. It dropped, as 112 investors sold GE shares while 818 reduced holdings. 106 funds opened positions while 696 raised stakes. The stock of AbbVie Inc. Northern holds 0.78% or 76.79M shares. Jacobs And Ca invested in 75,775 shares or 1.27% of the stock. Prudential Fincl has invested 0% in T-Mobile US, Inc. E&G Advsrs Limited Partnership has invested 1.63% in Apple Inc. (NYSE:T). Cranbrook Wealth Limited Liability Corporation holds 389 shares or 0.01% of its portfolio. Moreover, California Employees Retirement has 0% invested in LSB Industries, Inc. (NYSE:ABBV). Rdl, Virginia-based fund reported 11,108 shares. Maryland Cap Management invested 0.63% in General Electric Company (NYSE:GE). 1832 Asset Mgmt Lp has 0% invested in AbbVie Inc. Stevens First Principles Inv Advisors reported 0% of its portfolio in AbbVie Inc. (NYSE:ABBV). Amica Retiree Medical Tru holds 0.68% in AbbVie Inc. Goldcorp Inc. had 56 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of LSB Industries, Inc. (NYSE:ABBV) has "Buy" rating given on Monday, May 29 by Jefferies. Woodford Investment Management Ltd now owns 11,854,758 shares of the company's stock valued at $859,589,000 after buying an additional 937,500 shares in the last quarter. The firm earned "Positive" rating on Monday, August 17 by Pacific Crest. The company was maintained on Wednesday, June 14 by TD Securities. The Verity & Verity Llc holds 45,202 shares with $4.02 million value, up from 37,447 last quarter.

Muzinich & Co. Inc. holds 19.79% of its portfolio in Ares Capital Corporation for 12.20 million shares.

Bank Of Hawaii increased The Howard Hughes Corp (NYSE:HHC) stake by 2,795 shares to 7,493 valued at $884,000 in 2017Q3.

Several other institutional investors also recently modified their holdings of the company. (NYSE:AVY) by 4,580 shares in the quarter, for a total of 9,907 shares, and has risen its stake in Walgreens Boots Alliance Inc.

Since July 31, 2017, it had 0 buys, and 8 sales for $45.57 million activity. Another trade for 193,131 shares valued at $13.71 million was sold by GONZALEZ RICHARD A. The insider RICHMOND TIMOTHY J. sold $8.57M. On Monday, July 31 Gosebruch Henry O sold $21,127 worth of AbbVie Inc.

AbbVie Inc. has a consensus outperform rating from 22 Wall Street analysts, and the number of shares now sold short amount to at least 1.06% of shares outstanding. (NYSE:ABBV) was sold by SALEKI-GERHARDT AZITA on Monday, September 11.

Mairs & Power INC cut its stake in shares of AbbVie Inc. (NYSE:ABBV) or 18,300 shares. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 13, 2017 and is uptrending. Therefore 52% are positive. During the same quarter in the previous year, the firm posted $1.21 EPS. research analysts forecast that AbbVie Inc will post 5.55 EPS for the current fiscal year. Leerink Swann initiated it with "Mkt Perform" rating and $70 target in Tuesday, October 18 report. The legal version of this article can be viewed at https://baseballnewssource.com/markets/bristol-advisors-llc-buys-shares-of-3011-abbvie-inc-abbv/1829130.html. Jefferies Group increased their price target on shares of AbbVie from $107.00 to $115.00 and gave the company a "buy" rating in a report on Monday, October 16th. After $1.41 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.

The company's consensus rating on Reuter's scale remained unchanged from 3 to 3 during a month. Cannell Peter B Comm Inc holds 0.37% or 437,040 shares. The firm earned "Hold" rating on Thursday, July 20 by Credit Suisse. AbbVie now has a consensus rating of "Buy" and a consensus target price of $100.94. The company was maintained on Thursday, September 28 by Piper Jaffray. UBS Group reiterated a "neutral" rating on shares of AbbVie in a research note on Friday, October 13th. Jefferies maintained the shares of ABBV in report on Monday, May 29 with "Buy" rating.

Investors sentiment decreased to 0.85 in Q3 2017. Its up 0.02, from 1.15 in 2017Q2. 132 funds opened positions while 462 raised stakes. 779.91 million shares or 1.33% less from 790.40 million shares in 2017Q2 were reported. (NYSE:ABBV). Pekin Singer Strauss Asset Mgmt Il holds 0.87% or 52,171 shares. Great West Life Assurance Can reported 1.42 million shares. Hanson And Doremus has invested 0.21% in AbbVie Inc. (NYSE:ABBV). State Street owns 0.52% invested in AbbVie Inc. (NYSE:ABBV). Vestor Ltd Llc owns 8,175 shares. Finally, Woodford Investment Management Ltd increased its position in shares of AbbVie by 8.6% in the 2nd quarter. Corvex Mngmt L P holds 337,665 shares or 0.78% of its portfolio. Delphi Ma holds 32,949 shares. The fund owned 55,866 shares of the company's stock after selling 30,161 shares during the quarter. (NYSE:ABBV) for 166,607 shares. Cambridge Trust Com reported 0.38% stake. Adirondack Trust Co has 0.68% invested in AbbVie Inc. (NYSE:ABBV) for 68.25 million shares. Wendell David Assoc holds 1.89% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 3,494 shares. Five analysts have made estimates for AbbVie's earnings. (NYSE:ABBV) by 1.0% during the third quarter, according to its most recent Form 13F filing with the SEC.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER